# Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation

Study · id `cardio:ct-nct02426944` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02426944](<https://clinicaltrials.gov/study/NCT02426944>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02426944

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02426944. Randomized; no masking; primary purpose prevention. Start 2015-10-13 (actual); primary completion 2019-07-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02426944, source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)
- Started: 2015-10-13 (actual) (ClinicalTrials.gov record NCT02426944, source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)
- Primary completion: 2019-07-20 (actual) (ClinicalTrials.gov record NCT02426944, source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)
- Completion: 2019-07-20 (actual) (ClinicalTrials.gov record NCT02426944, source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)
- Countries: Czechia (ClinicalTrials.gov record NCT02426944, source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02426944-2021-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation
- Acronym: PRAGUE-17
- Condition: Atrial Fibrillation
- Intervention (Drug): NOAC
- Intervention (Device): Left atrial appendage closure
- Lead sponsor: Charles University, Czech Republic
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Czech Republic
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Charles University, Czech Republic (`cardio:org-charles-university-czech-republic`)
- Registry lists this organization as a collaborator: Ministry of Health, Czech Republic (`cardio:org-ministry-of-health-czech-republic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation (`cardio:pubmed-32586585`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation (`cardio:pubmed-34748929`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c3f7da45e32582c133f6e5c6cde103b050be122a021ed47509ff608b43f6a6a0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
